The study achieved primary efficacy endpoints, showing significant reductions in frequency and severity at week four.
Acarix will launch the CADScor system in the UAE through UniTech Solutions, which will manage regional distribution.
As part of the deal, Actio Biosciences will spin out a new company focused on genetic rare neurological diseases.
The procedure was carried out at the CARTI Cancer Center Little Rock, Arkansas, US.
